In particular, obese women have a reduced risk of hormone receptor (HR)-positive premenopausal BC and an increased risk of HR-positive postmenopausal BC compared to women with a normal BMI, whereby the precise mechanism of these paradoxical effects remains elusive [5, 37, 38]. This evidence concerns the gene NR4A1 and breast cancer.